Walleye Capital’s Cellebrite CLBT Stock Holding History

Walleye Capital’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$438	Buy	+30	New	+$396	﹤0.01%	4620
2026 Q1	–	Sell	-1	Closed	-$15	–	4468
2025 Q4	$18	Sell	1 -160	-99%	-$2.87K	﹤0.01%	4468
2025 Q3	$2.98K	Sell	161 -1,422	-90%	-$22.3K	﹤0.01%	4338
2025 Q2	$25.3K	Sell	1,583 -112,986	-99%	-$2.01M	﹤0.01%	4199
2025 Q1	$2.23M	Sell	114,569 -785,166	-87%	-$16.5M	0.01%	1332
2024 Q4	$19.8M	Sell	899,735 -290,312	-24%	-$5.59M	0.05%	334
2024 Q3	$20M	Buy	1,190,047 +70,337	+6%	+$1.04M	0.04%	329
2024 Q2	$13.4M	Buy	1,119,710 +37,045	+3%	+$414K	0.02%	579
2024 Q1	$12M	Buy	1,082,665 +836,452	+340%	+$8.54M	0.02%	728
2023 Q4	$2.13M	Buy	+246,213	New	+$1.91M	﹤0.01%	1736

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Walleye Capital's CLBT Position: Q2 2026 in Review

Walleye Capital opened a new position in Cellebrite (CLBT) in Q2 2026: 30 shares worth $438. The stake represents ﹤0.01% of the portfolio and ranks #4620 among its holdings. This is a return to the name: Walleye Capital previously reported a position in CLBT as recently as Q4 2025.

Walleye Capital first reported a position in CLBT in Q4 2023 and has held it in 10 quarters since. The position peaked at $20M in Q3 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Walleye Capital held 30 shares of Cellebrite worth $438 as of Q2 2026.
Cellebrite was a new Walleye Capital position in Q2 2026.
Cellebrite made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4620 holding.
Walleye Capital first reported a position in Cellebrite in Q4 2023 and has held it in 10 quarters since.
Walleye Capital's Cellebrite position peaked at $20M in Q3 2024.
201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.